CYduct Diagnostics, Inc. Stock

Equities

CYDX

US23256Q1058

Market Closed - OTC Markets 15:49:37 2024-05-20 EDT 5-day change 1st Jan Change
0.305 USD -12.86% Intraday chart for CYduct Diagnostics, Inc. -12.86% -40.20%
Sales 2010 429K 590K Sales 2011 329K 451K Capitalization 396K 544K
Net income 2010 -1M -1.37M Net income 2011 - 0 EV / Sales 2010 0.87 x
Net Debt 2010 265K 364K Net Debt 2011 167K 229K EV / Sales 2011 1.71 x
P/E ratio 2010 *
-
P/E ratio 2011
-
Employees 4
Yield 2010 *
-
Yield 2011
-
Free-Float 0%
More Fundamentals * Assessed data
Dynamic Chart
CYduct Diagnostics, Inc. Announces Positive Study Results for Biomarker Combinations in the Assessment of Breast Cancer CI
CYduct Diagnostics, Inc. announced a financing transaction CI
CYduct Diagnostics, Inc. (OTCPK:SNDY.D) completed the acquisition of all the assets of HHC PREFERRED LLC. CI
CYduct Diagnostics, Inc. (OTCPK:SNDY.D) signed a letter of intent to acquire all the assets of HHC PREFERRED LLC. CI
Solos Endoscopy, Inc. acquired Assets of CYduct, LLC. CI
Solos Endoscopy, Inc. Appoints Dom Gatto as CEO and Chairman of the Board CI
Solos Endoscopy, Inc. Announces Resignation of Robert Segersten as CEO and Chairman of the Board CI
Dom Gatto Joins to the Board of Directors of Solos Endoscopy, Inc CI
American Medical Group LLC acquired a controlling stake in Solos Endoscopy, Inc. (OTCPK : SNDY) from Bob Segersten. CI
Solos Endoscopy, Inc. will Change its Ticker to SNDY from SNDYD CI
Solos Endoscopy to Begin Distribution of its Endoscopic Instruments in Canada CI
Solos Endoscopy, Inc. Announces Earnings Results for the Second Quarter and Six Months Ended June 30, 2013 CI
Solos Endoscopy, Inc. Announces Sales Results for the Twelve Months Period Ended 2012 and for the Months October, November and December 2012 CI
Solos Endoscopy, Inc. to Conduct New Testing to Increase Sterilization Life for its MammoView Breast Endoscopy Product Line CI
Solos Endoscopy, Inc. Reports Earnings Results for the Six Months Ended June 30, 2012; Provides Cash Flow Guidance CI
More news
1 day-12.86%
1 week-12.86%
Current month+1.67%
1 month+1.67%
3 months-25.61%
6 months-40.20%
Current year-40.20%
More quotes
1 week
0.31
Extreme 0.305
0.31
1 month
0.31
Extreme 0.305
0.35
Current year
0.30
Extreme 0.3
0.51
1 year
0.30
Extreme 0.3
0.60
3 years
0.07
Extreme 0.0701
1.56
5 years
0.06
Extreme 0.06
4.89
10 years
0.06
Extreme 0.06
450.05
More quotes
Managers TitleAgeSince
Chief Executive Officer 63 17-06-14
Director of Finance/CFO - -
Chief Operating Officer 66 -
Members of the board TitleAgeSince
Chief Operating Officer 66 -
Chief Executive Officer 63 17-06-14
More insiders
Date Price Change Volume

Delayed Quote OTC Markets, May 20, 2024 at 03:49 pm

More quotes